Accrol analyst briefing to be held on 26 September 2023

[shareaholic app="share_buttons" id_name="post_below_content"]

Accrol Group Holdings plc (LON:ACRL), the UK’s leading independent tissue converter, has announced that it will release its Final Results for the year ended 30 April 2023 on Tuesday, 26 September 2023.

An analyst briefing will be held online at 9.00 am on that day. Equity analysts interested in joining the meeting should contact Belvedere Communications.

As part of the Accrol Group’s Results roadshow, the management will host an online investor presentation and Q&A session. This will take place on Monday, 2 October at 1.00pm. Anyone wishing to participate should register for the event with PI World at: https://bit.ly/ACRL_FY23_webinar

You might also enjoy reading Accrol Group Holdings plc cancelled from trading on AIM

Written by: Amilia Stone

Find more news, interviews, share price & company profile here for:
Accrol Group Holdings

Latest Company News

Accrol Group Holdings plc cancelled from trading on AIM

Accrol Group publishes Shareholder Circular for Scheme Document and Offer Terms

Accrol Group Holdings plc (LON:ACRL) has announced the publication of a shareholder circular detailing terms of the Scheme. Learn more here.

Accrol Group Holdings Results Presentation 2024 (VIDEO)

Discover the latest results and overview of Accrol Group Holdings, the UK's top independent tissue converter, led by CEO Gareth Jenkins and CFO Chris Welsh.

Gervais Williams UK Stocks to Watch in 2024

In this interview, Gervais Williams, co-fund manager of Miton UK MicroCap Trust, discusses navigating the economic landscape and standout companies in 2024. Find out more here. #investment #microcap

Accrol Group Holdings: strong margins and volume growth continues into H2, says Shore Capital

Accrol Group Holdings plc has reported strong H1 FY24 results, with impressive growth in adjusted EBITDA and adjusted PBT. The company remains on track to meet expectations and has seen gains in market share. Furthermore, the private label segment of the UK tissue market continues to increase, and the sales of biodegradable wet wipes have been exceptionally strong. Accrol's outlook remains positive with expected further volume growth.

Accrol Group Holdings plc: Strong performance in H1 FY24, expects to outperform in FY25

Accrol Group Holdings plc has reported strong performance in H1 FY24, with branded volumes rising by 45% and margins returning to pre-pandemic levels. The group is on track to deliver FY24 results in line with expectations and expects to outperform previous expectations for FY25.

Accrol analyst briefing to be held on 26 September 2023

We’ll keep you in the loop!

Search

Useful links

Disclaimer